The most common projected cancers in adults were lung cancer, colon cancer, leukemia, bladder cancer, and stomach cancer.

“Our results suggest that the new definition of epilepsy results in a higher frequency of epilepsy diagnosis and treatment,” the authors write. “Short-term outcomes improved (one-year recurrence rate ...

By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM.

HealthDay News — The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research ...

HealthDay News — Among individuals eligible for lung cancer screening (LCS), use of breast cancer screening (BCS) and colorectal cancer screening (CCS) is much higher than use of LCS, according to a ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

Seventy-four percent of respondents unaware of FDA-approved treatments; 56% said these options had not been discussed by clinician.

The randomized, double-blind, placebo-controlled ODYSSEY-HCM trial included 580 adult patients with symptomatic nonobstructive HCM.

To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and promote the use of lab-grown human organoids (tiny, self-organized ...